NCT06059417

Brief Summary

Foam tape is commonly used in the emergency department as a dressing over chest tubes owing to its occlusive and compressible properties. There is a paucity of data regarding the incidence of significant cutaneous reactions to this material. The investigators conducted a prospective trial to evaluate the incidence of dermatitis following application of foam tape to the upper arm of a cohort of healthy volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 13, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 13, 2022

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 22, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 28, 2023

Completed
Last Updated

July 26, 2024

Status Verified

July 1, 2024

Enrollment Period

1.1 years

First QC Date

September 22, 2023

Last Update Submit

July 24, 2024

Conditions

Keywords

DermatologyContact Dermatitis

Outcome Measures

Primary Outcomes (1)

  • Cutaneous Irritancy Scoring System

    A score will be assigned to the test area using the established Cutaneous Irritancy Scoring System. Using an established scoring system grading based on erythema and edema, a cumulative score will be obtained by adding erythema and edema. A score of 0 is no reaction. A score of 1-3 is mild, 4-5 is moderate, and 6-8 severe.

    48 hours

Study Arms (1)

Foam-tape/Control

OTHER

One of the participants upper extremity (arm) was used for intervention and the same participants other arm was used as the control in this study. There was only 1 research arm in this study and all study participants were in it.

Other: 2x2 inch piece of 3M microfoam adhesive

Interventions

A 2x2 inch piece of 3M microfoam adhesive will be applied to the medial aspect of the subject's upper arm. The adhesive will remain in place for 48 hours at which time an investigator will remove the adhesive and assess the study area. A numerical value will be assigned based on the Cutaneous Irritancy Scoring System (CISS). The study site will be compared to the contra-lateral upper extremity at the end of the 48 hour period.

Foam-tape/Control

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 - 70
  • No reported history of dermatologic conditions
  • No active dermatologic lesions
  • Able to provide written consent to participation in the study.
  • Resident and/or ancillary staff

You may not qualify if:

  • Hospitalized patients
  • Adults unable to consent.
  • Prisoners
  • Adults with anaphylaxis to medical adhesives

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHRISTUS Health/Texas A&M Health Science Center

Corpus Christi, Texas, 78404, United States

Location

CHRISTUS Health

Corpus Christi, Texas, 78404, United States

Location

Related Publications (5)

  • Smith SM, Zirwas MJ. Nonallergic reactions to medical tapes. Dermatitis. 2015 Jan-Feb;26(1):38-43. doi: 10.1097/DER.0000000000000098.

  • Widman TJ, Oostman H, Storrs FJ. Allergic contact dermatitis from medical adhesive bandages in patients who report having a reaction to medical bandages. Dermatitis. 2008 Jan-Feb;19(1):32-7.

  • Dykes PJ. The effect of adhesive dressing edges on cutaneous irritancy and skin barrier function. J Wound Care. 2007 Mar;16(3):97-100. doi: 10.12968/jowc.2007.16.3.27013.

  • Wood MD, Powers J, Rechter JL. Comparative Evaluation of Chest Tube Insertion Site Dressings: A Randomized Controlled Trial. Am J Crit Care. 2019 Nov;28(6):415-423. doi: 10.4037/ajcc2019645.

  • Vo NH, Richman P, Torres R, Xu KT, Miller M. The incidence of dermatitis following application of foam tape in healthy volunteers-A prospective trial. Am J Emerg Med. 2024 May;79:212-213. doi: 10.1016/j.ajem.2024.02.043. Epub 2024 Mar 5.

MeSH Terms

Conditions

Dermatitis, Contact

Condition Hierarchy (Ancestors)

DermatitisSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, Eczematous

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: A cohort of consenting, healthy physicians, nurses, and ancillary staff at a teaching facility who did not have known hypersensitivity to foam tape were enrolled. Study investigators applied a 2x2 inch piece of 3M micro-foam adhesive to the medial aspect of each subject's upper arm. The contralateral arm served as a reference for comparison. The adhesive remained in place for 48 hours and the study authors assessed patients utilizing the previously validated Cutaneous Irritancy Scoring System (CISS).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2023

First Posted

September 28, 2023

Study Start

August 1, 2021

Primary Completion

September 13, 2022

Study Completion

September 13, 2022

Last Updated

July 26, 2024

Record last verified: 2024-07

Locations